Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00850018 · ClinicalTrials.gov registry record · Phase 1
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study
A Phase 1 study of Anemia, Sickle Cell, sponsored by UCSF Benioff Children's Hospital Oakland.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
- 14
- Study locations
NCT00850018: Completed Phase 1 study of Anemia, Sickle Cell, sponsored by UCSF Benioff Children's Hospital Oakland.
NCT00850018 is a Phase 1 study of Anemia, Sickle Cell that has completed, run by UCSF Benioff Children's Hospital Oakland. The registered enrollment target is 36 participants, below the 116-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (69% lower). The trial reports 14 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00850018, a Phase 1 study of Anemia, Sickle Cell, has completed, sponsored by UCSF Benioff Children's Hospital Oakland.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
- 14
- Study locations
Study Summary
Sickle cell disease (SCD), also known as sickle cell anemia, is an inherited blood disease that can cause intense pain episodes and may lead to organ failure. Preliminary studies have shown that adults with SCD may have brain abnormalities that contribute to problems with cognitive functioning, including attention and memory difficulties. This study will use brain magnetic resonance imaging (MRI) and neuropsychological testing to examine the differences in cognitive functioning in adults with SCD who are treated for anemia with monthly blood transfusions for 6 months versus adults with SCD who receive usual care for 6 months.
Conditions Studied
Interventions
- BEHAVIORAL Usual care
- PROCEDURE Monthly blood transfusion regimen
Study Locations (14)
Florida
- Memorial Cancer Institute - Hollywood
- University of Miami Miller School of Medicine - Miami
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
- Duke University Medical Center - Durham
Ohio
- Cincinnati Children's Hospital - Cincinnati
- University of Cincinnati Medical Center - Cincinnati
California
- Children's Hospital & Research Center at Oakland - Oakland
District of Columbia
- Howard University - Washington D.C.
Georgia
- Medical College of Georgia - Augusta
Maryland
- Johns Hopkins - Baltimore
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2004-12 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
What the finished NCT00850018 record still lists
NCT00850018 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 116-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Anemia, Sickle Cell appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT00850018 lists 14 locations in 11 states (Florida, North Carolina, Ohio).
Frequently Asked Questions
What is clinical trial NCT00850018 about?
NCT00850018 is a clinical study titled "Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study". Sickle cell disease (SCD), also known as sickle cell anemia, is an inherited blood disease that can cause intense pain episodes and may lead to organ failure. Preliminary studies have shown that adults with SCD may have brain abnormalities that contribute to problems with cognitive functioning, incl...
What is the current status of trial NCT00850018?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2004-12. Estimated completion is 2010-12.
What conditions does trial NCT00850018 study?
This clinical trial studies the following conditions: Anemia, Sickle Cell.
What interventions are being tested in trial NCT00850018?
The interventions under investigation include: Usual care (BEHAVIORAL), Monthly blood transfusion regimen (PROCEDURE).
Who is sponsoring clinical trial NCT00850018?
This trial is sponsored by UCSF Benioff Children's Hospital Oakland, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00850018 being conducted?
This trial has 14 study locations across California, District of Columbia, Florida, Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia, Sickle Cell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00850018's enrollment target sits among peer trials
36 13th of 17 higher than 5 of 17 other Anemia, Sickle Cell trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia, Sickle Cell trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
RECRUITING · Phase 1
-
A Blood Stem Cell Transplant for Sickle Cell Disease
ACTIVE NOT RECRUITING · Phase 1
-
Hydroxyurea and EPO in Sickle Cell Disease
COMPLETED · Phase 1
-
A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
RECRUITING · Phase 2
-
Metabolic and Hemodynamic Reserve in Pediatric SCA
RECRUITING · NA
-
Therapeutic Response Evaluation and Adherence Trial (TREAT)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia